|Bid||0.0000 x 900|
|Ask||0.0000 x 1400|
|Day's range||0.8400 - 0.9200|
|52-week range||0.6301 - 6.2000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||16 Mar 2022 - 21 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.00|
Progenity (NASDAQ: PROG), a biotech company and a meme stock favorite, saw its shares decline more than 11% on Wednesday. Overall, Progenity stock is down more than 47% this year. The markets don't like uncertainty, and that's one reason Progenity has trended downward.
Shares of Progenity (NASDAQ: PROG) were up more than 34% on Tuesday. At the time of its initial public offering in 2020, the biotech company went for $13 a share, and the stock has been highly volatile because it is a retail investor favorite. It is the second time in less than a month that Progenity has taken off on a short-squeeze-fueled frenzy.
Progenity, Inc. ( NASDAQ:PROG ) shareholders will doubtless be very grateful to see the share price up 107% in the last...